OptimizeRx (OPRX) Consolidated Net Income (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Consolidated Net Income data on file, last reported at -$495000.0 in Q1 2026.

• For the quarter ending Q1 2026, Consolidated Net Income rose 77.49% year-over-year to -$495000.0; the trailing twelve-month figure through Mar 2026 stood at $6.8 million (up 144.36% YoY), and the FY2025 full-year result was $5.1 million, up 125.52% from the prior year.
• Consolidated Net Income eased to -$495000.0 in Q1 2026, from $5.0 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $5.0 million in Q4 2025 to a low of -$11.7 million in Q4 2023.
• A 5-year average of -$3.1 million and a median of -$3.5 million in 2022 frame the typical range for Consolidated Net Income.
• Across the five-year window, Consolidated Net Income tumbled 8790.01% in 2022 and surged 6535.9% in 2025, its largest moves.
• Tracing OPRX's Consolidated Net Income over 5 years: stood at -$325836.0 in 2022, then slumped by 3503.04% to -$11.7 million in 2023, then soared by 99.34% to -$78000.0 in 2024, then surged by 6535.9% to $5.0 million in 2025, then sank by 109.86% to -$495000.0 in 2026.
• Business Quant data shows OPRX's Consolidated Net Income at -$495000.0 in Q1 2026, $5.0 million in Q4 2025, and $779000.0 in Q3 2025.